Moreover, treatment with activator 3 (SIRT1 activator) can significantly reduce cerebral infarction volume in MCAO mice, possibly via inhibition of NF-κB induced inflammation and apoptosis pathways [34]. Here, SIRT1 is linked to cerebral infarction.